Clomipramine recalls
The FDA has published 8 recalls involving Clomipramine since 2014. The latest was reported on 12 Nov 2025. Most were for potency & assay. Zydus Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls8since 2014
Last 12 months3reported
Class I00% of total
Ongoing3latest 12 Nov 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 7 88%Class III 1 13%
Why clomipramine is recalled
Companies
By year
Ongoing clomipramine recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg recalledClomipramine Hydrochloride | Zydus Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | clomiPRAMINE Hydrochloride, Capsules, USP, 50 mg recalledClomipramine Hydrochloride | Zydus Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg recalledClomipramine Hydrochloride | Zydus Pharmaceuticals | Nitrosamine Impurity | Nationwide |
All clomipramine recalls, newest first
8 totalShould you stop taking Clomipramine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.